CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
CareDx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$67.08+3.08 (+4.81%)
Close on Oct 19, 2026
- Market cap
- $3.58B
- P/E (TTM)
- 32.4
- Dividend yield
- –
Share price
+$52.67 (+365.5%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CareDx, Inc. grew revenue 34.4% to $458.09M over the twelve months to Jun 30, 2026. Operating income rose 134.2% to $108.14M, moving the operating margin from 13.5% to 23.6%.
Revenue
$458.09M
+34.4% vs. a year earlier
Operating income
$108.14M
+134.2% vs. a year earlier
EPS, diluted
$2.07
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.58B
- P/E ratio
- 32.4
- Price to sales
- 7.82
- Price to book
- 8.42
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $458.09M
- Net income
- $111.01M
- EPS, diluted
- $2.07
- Book value per share
- $7.97
- Diluted shares
- 53M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$458.09M+34.4% YoY
Gross profit
–
Operating income
$108.14M+134.2% YoY
Net income
$111.01M+90.9% YoY
EPS, diluted
$2.07
Free cash flow
–
Reported periodTrailing twelve months